DNA could be detected, and the primers only amplified DNA from A. fumigatus and not any other fungal, bacterial, viral, or human DNA tested. Using the PCR, we were able to detect A. fumigatus DNA in lung homogenates from immunosuppressed mice experimentally infected with A. fumigatus but not from immunosuppressed uninfected controls. There was 93% correlation between the culture results and the PCR results. In a retrospective clinical study, the sensitivity of the PCR for the detection ofA.fumigatus in clinical samples was confirmed by positive amplification in three of three culture-positive respiratory samples from confirmed cases of IA. Because isolation ofAspergillus spp. may reflect contamination and colonization without infection, the feasibility of using the PCR was evaluated by analyzing culture-negative samples from both immunosuppressed patients at high risk for IA and immunocompetent patients with other lung infections. Only 2 of 10 patients were culture negative and PCR positive in the high-risk group, and 2 of 7 patients were culture negative and PCR positive in the immunocompetent group. The results indicate that PCR detection might be a valuable adjunct to current laboratory methods to diagnose IA. Invasive aspergillosis (IA) is caused by opportunistic infection with pathogenic Aspegillus species and is a major hazard for immunocompromised patients. Those particularly at risk are leukemia patients with cytotoxic drug-induced neutropenia and bone marrow and organ transplant recipients receiving high-dose corticosteroid therapy. It has been shown previously that up to 41% of patients who died of acute leukemia had evidence of aspergillosis (10) . Aspergillus fumigatus is the most common species associated with IA, and once the disease is established, it is refractory to treatment. Amphotericin B is still the mainstay of antifungal chemotherapy, but its efficacy is limited owing to its acute nephrotoxicity. Early diagnosis, therefore, remains the key to a favorable outcome (1) . Clinical diagnosis of IA is difficult and is largely presumptive, typically based on the presence of spiking fevers not responding to antibiotics in a patient with the known risk factors outlined above. The clinical samples most often available for microbiological diagnosis are bronchial washings and bronchoalveolar lavage (BAL) fluids. Positive culture of Aspergillus spp., although indicative, is not proof of infection, and the "gold standard" is mycological and/or histological evidence of tissue invasion, which is not always easy to obtain. There have been some successful attempts to use serological assays to detect circulating antibodies to Aspergillus spp. in the noninvasive form of the disease, e.g., allergic bronchopulmonary aspergillosis and aspergilloma, but generally immunosuppressed patients generate a poor antibody response. Tests based on the detection of Aspergillus cell wall antigens suffer from lack of sensitivity (19) , and sequential sampling is often required (4, 13, 14) . The polymerase chain reaction (PCR) has already been used to detect DNA from a number of pathogens when diagnostic methods are limited (3, 11, 16, 18) , and its use to amplify specific sequences of DNA from A. fumigatus followed by agarose gel electrophoresis and simple visualization with UV light would be a much needed addition to conventional laboratory methods. It is highly sensitive and a result could be obtained on the same day, which would be an improvement on standard methods. We report for the first time the use of the PCR for the detection of A. fumigatus. The aim of the study was (8), and exposed to X-ray film for various lengths of time at -70°C, typically 1 h and overnight. Southern hybridizations were performed by using the internal DNA probe to confirm that the DNA products were amplified from the rDNA region and that any unexpected products were the result of non-specific amplification.
RESULTS
Sensitivity and specificity studies. PCRs with primers based on the 26S/intergenic spacer region of the rDNA complex were sensitive enough to detect 1 pg of A. fumigatus DNA by UV visualization (Fig. 1A) and as little as 100 fg following Southern analysis (Fig. 1B) . The 401-bp fragment from all A. fiumigatus isolates but not from any of theA. fiavus, A. niger, andA. nidulans isolates. Some other fragments were amplified from the DNA of the two Penicillium spp. and several of the Aspergillus spp., including multiple fragments for A. terreus, but the 401-bp fragment was only amplified from the A. fumigatus DNA (Fig.  2A) . This specificity was confirmed following Southern hybridization (Fig. 2B) .
Animal model of IA. A summary of the survival, culture, histology, and PCR results is given in Table 3 . Multiple foci of IA were present in the lung samples that were histology positive. The correlation between the PCR and the culture results was 93% (14 of 15) by UV visualization (Fig. 3A) . Following the PCR, the DNA from the healthy nonimmunosuppressed mouse control was negative, and the controls in which A. fumigatus DNA was added or omitted were positive and negative, respectively. DNA fragments other than the 401-bp fragment were amplified from all mouse DNA samples (Fig. 3A) , but these did not hybridize to the internal DNA probe, showing that they were a result of nonspecific amplification (Fig. 3B) (Fig. 4A) . All three of the group 1 samples were PCR positive (100%). Two of the group 1 patients died of IA, but one patient's (patient 1) infection resolved following amphotericin B treatment. The sputum sample in group 2 was also positive, suggesting that the patient may have hadAspezgillus infection; however, the nature of the sample analyzed makes it difficult to draw firm conclusions. The other two group 2 samples appeared to be negative, although the large amount of DNA in some of the samples could have masked any amplified fragment (particularly in lane 5, Fig. 4A ). Indeed, following Southern hybridization and overnight autoradiography (Fig. 4B) , there were faint bands visible in these samples. This indicates that, despite the high concentration of template DNA in the PCR mixes, there must have been a very small amount of A. fumigatus DNA present. This would correlate with the low yield of DNA one might expect from colonizing Aspergillus spp. as opposed to active infection. Eight of the 10 (80%) group 3 samples were PCR negative. There were two positive samples: one was from a bone marrow transplant patient with a lung shadow who later died of cytomegalovirus pneumonitis, and the other was from a sarcoidosis patient who had been receiving prednisone and cyclophosphamide. Without any histopathological data, it is difficult to speculate whether these patients had invasive infection. Faint bands were detected following Southern hybridization of three more samples, one from a bone marrow transplant patient (who was later discharged without further complications) and another from patient 1. Two samples were received from this patient: the first one, a bronchial washing, was culture negative (and thus placed in group 3) and after a 3-week interval a BAL was cultured and found positive; thus, the sample was placed in group One of the most important considerations in the possible clinical evaluation of the PCR forAspegillAus detection is the possibility of false-positive results being generated from Aspergillus spp. colonizing the respiratory tract without causing active disease. We were encouraged to find that the culture-positive samples in group 2 were only PCR positive following DNA hybridization (except the sputum sample) and that samples from patients known to have IA were clearly positive by UV visualization only. There were two false-positive samples in each of groups 3 and 4, and indeed from the clinical histories it seems that some of these patients were particularly likely to develop colonization. The data presented here show that it is possible to generate primers which have the necessary sensitivity and specificity to detect A. fumigatus DNA in clinical samples. These preliminary data would also seem to confirm the legitimacy of using the PCR for the diagnosis of IA as long as the results are interpreted with care and with full consideration of the clinical facts. Results based on DNA hybridization are probably too sensitive to give a reliable diagnosis and should not be used. Clearly, the procedure described here would not immediately lend itself to routine laboratory diagnosis; however, new technology towards simplifying and automating the PCR is being developed, and this will make PCR diagnosis more amenable to the clinical laboratory.
The utility of this approach in everyday practice now needs to be evaluated in a prospective fashion in a large population of patients, and this work is under way.
